Pseudomyxoma peritonei epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (12 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pseudomyxoma peritonei}} | {{Pseudomyxoma peritonei}} | ||
{{CMG}}{{AE}}{{ | {{CMG}}{{AE}}{{Nnasiri}} | ||
==Overview== | ==Overview== | ||
Pseudomyxoma peritonei is a very rare tumor characterized by the presence of abundant mucus in the [[abdominal]] cavity, it is more common in females and usually arises from an appendiceal tumor, but it can originate from [[ovary]] or [[colon]] as well. It has an incident rate of 0.1 cases per 100,000 people per year. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
*The overall incidence of pseudomyxoma peritonei is 0. | *The overall [[incidence]] of pseudomyxoma peritonei is 0.1 cases per 100,000 people per year. <ref name="pmid17524597">{{cite journal |vauthors=Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA |title=Appendiceal neoplasms and pseudomyxoma peritonei: a population based study |journal=Eur J Surg Oncol |volume=34 |issue=2 |pages=196–201 |date=February 2008 |pmid=17524597 |doi=10.1016/j.ejso.2007.04.002 |url=}}</ref><ref name="pmid18043976">{{cite journal |vauthors=Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M |title=Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) |journal=Ann. Surg. Oncol. |volume=15 |issue=2 |pages=526–34 |date=February 2008 |pmid=18043976 |doi=10.1245/s10434-007-9691-2 |url=}}</ref> | ||
*Pseudomyxoma peritonei is slightly more common in females than males | *Pseudomyxoma peritonei is slightly more common in females than males. | ||
*The median age at presentation is typically about 50 years of age. | *The median age at presentation is typically about 50 years of age. | ||
| Line 13: | Line 13: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | [[Category:Oncology]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
[[Category: | [[Category:Pseudomyxoma peritonei]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 13:05, 2 April 2019
|
Pseudomyxoma peritonei Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pseudomyxoma peritonei epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Pseudomyxoma peritonei epidemiology and demographics |
|
Pseudomyxoma peritonei epidemiology and demographics in the news |
|
Blogs on Pseudomyxoma peritonei epidemiology and demographics |
|
Risk calculators and risk factors for Pseudomyxoma peritonei epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Overview
Pseudomyxoma peritonei is a very rare tumor characterized by the presence of abundant mucus in the abdominal cavity, it is more common in females and usually arises from an appendiceal tumor, but it can originate from ovary or colon as well. It has an incident rate of 0.1 cases per 100,000 people per year.
Epidemiology and Demographics
- The overall incidence of pseudomyxoma peritonei is 0.1 cases per 100,000 people per year. [1][2]
- Pseudomyxoma peritonei is slightly more common in females than males.
- The median age at presentation is typically about 50 years of age.
References
- ↑ Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA (February 2008). "Appendiceal neoplasms and pseudomyxoma peritonei: a population based study". Eur J Surg Oncol. 34 (2): 196–201. doi:10.1016/j.ejso.2007.04.002. PMID 17524597.
- ↑ Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M (February 2008). "Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)". Ann. Surg. Oncol. 15 (2): 526–34. doi:10.1245/s10434-007-9691-2. PMID 18043976.